Literature DB >> 3260605

Multiple tissues express alpha 1-antitrypsin in transgenic mice and man.

J A Carlson1, B B Rogers, R N Sifers, H K Hawkins, M J Finegold, S L Woo.   

Abstract

Hepatocytes are considered to be the predominant source of alpha 1-antitrypsin (AAT), the major antiprotease in human plasma. The development of emphysema in the hereditary PiZ AAT deficiency state suggests that inhibition of leukocyte elastase in the lung is a major function of this protein. In addition, patients with AAT deficiency are at increased risk for developing cholestasis in infancy and chronic liver disease as adults. The mechanism for hepatic cell injury, however, is not understood. Transgenic mice that express the normal human AAT gene demonstrate abundant AAT in hepatocytes and specific cell types of numerous nonhepatic tissues. Immunoperoxidase techniques have previously disclosed AAT in many of the cell types seen in transgenic mice; however, the issue of local synthesis vs. endocytosis in these cell types has remained unresolved. In this study, AAT mRNA was seen in a variety of tissues in the transgenic mouse. Immunoelectron microscopy of renal tubular and small intestinal epithelial cells in the transgenic mice demonstrated AAT within the cisternae of the rough endoplasmic reticulum, as in hepatocytes. These findings support the possibility of local synthesis in the various cell types. The results suggest that in addition to maintaining tissue integrity in the lung, the protease/antiprotease balance may have physiological functions in other organs as well.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260605      PMCID: PMC303472          DOI: 10.1172/JCI113580

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Current concepts of liver structure as related to function.

Authors:  A L Jones; D L Schmucker
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Prevalence of alpha1-antitrypsin deficiency in patients with gastric or duodenal ulcer.

Authors:  F Andre; C Andre; R Lambert; F Descos
Journal:  Biomedicine       Date:  1974-05-20

3.  Alpha1-antitrypsin deficiency, emphysema, necrotizing angiitis and glomerulonephritis.

Authors:  F Miller; M Kuschner
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

4.  Properties of isolated human alpha1-antitrypsins of Pi types M, S and Z.

Authors:  J O Jeppsson; C B Laurell; M Fagerhol
Journal:  Eur J Biochem       Date:  1978-02-01

5.  Catabolic rate of alpha1-antitrypsin of Pi type M and Z in man.

Authors:  C B Laurell; B Nosslin; J O Jeppsson
Journal:  Clin Sci Mol Med       Date:  1977-05

6.  Immunoperoxidase techniques: practical and theoretical aspects.

Authors:  C R Taylor
Journal:  Arch Pathol Lab Med       Date:  1978-03       Impact factor: 5.534

7.  Membranoproliferative glomerulonephritis in childhood cirrhosis associated with alpha1-antitrypsin deficiency.

Authors:  S P Moroz; E Cutz; J W Balfe; A Sass-Kortsak
Journal:  Pediatrics       Date:  1976-02       Impact factor: 7.124

8.  Chronic pancreatitis and alpha-1-antitrypsin.

Authors:  B H Novis; G O Young; S Bank; I N Marks
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

9.  alpha-1-Antitrypsin immunoreactivity in islet cells of adult human pancreas.

Authors:  M B Ray; V J Desmet; W Gepts
Journal:  Cell Tissue Res       Date:  1977-11-30       Impact factor: 5.249

10.  Comparison of gastrointestinal loss of alpha-1-antitrypsin and chromium-51-albumin in Ménétrier's disease and the influence of ranitidine.

Authors:  W H Reinhart; K Weigand; M Kappeler; H Roesler; F Halter
Journal:  Digestion       Date:  1983       Impact factor: 3.216

View more
  45 in total

Review 1.  Molecular biology and respiratory disease. 7. The alpha 1 antitrypsin gene and chronic lung disease.

Authors:  N Kalsheker; K Morgan
Journal:  Thorax       Date:  1990-10       Impact factor: 9.139

Review 2.  Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.

Authors:  Nicholas Maurice; David H Perlmutter
Journal:  Clin Transl Sci       Date:  2012-01-10       Impact factor: 4.689

3.  Hepatic progenitor cell proliferation and liver injury in α-1-antitrypsin deficiency.

Authors:  Elizabeth M Brunt; Keith Blomenkamp; Muneeb Ahmed; Faiza Ali; Nancy Marcus; Jeffrey Teckman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-11       Impact factor: 2.839

4.  NFκB mitigates the pathological effects of misfolded α1-antitrypsin by activating autophagy and an integrated program of proteostasis mechanisms.

Authors:  Amitava Mukherjee; Tunda Hidvegi; Patrick Araya; Michael Ewing; Donna B Stolz; David H Perlmutter
Journal:  Cell Death Differ       Date:  2018-05-23       Impact factor: 15.828

5.  Endothelial cell associated anti-elastolytic activity.

Authors:  M E Hanley; L S Terada; J C Cheronis; J E Repine
Journal:  Inflammation       Date:  1996-06       Impact factor: 4.092

6.  Is fibrosing colonopathy an immune mediated disease?

Authors:  J Lee; W Ip; P Durie
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 7.  Autophagy in the liver: functions in health and disease.

Authors:  Takashi Ueno; Masaaki Komatsu
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-01-05       Impact factor: 46.802

Review 8.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

9.  Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium.

Authors:  E P Molmenti; D H Perlmutter; D C Rubin
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

Review 10.  Utilization of transgenic mice in the study of matrix degrading proteinases and their inhibitors.

Authors:  R Khokha; D C Martin; J E Fata
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.